fairplus stamp

CARE

Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity


Primary Purpose
In vitro drug screening
Study Types
Clinical trial Target identification Drug discovery Drug repurposing
Description of Cohorts
-
Informed Consent Given?
-
Multi-center Study?
-
Organisms
Chlorocebus sabaeus
Number of subjects
-
Diseases
respiratory disease infectious disease COVID-19
Sample Sources
Vero E6 (green monkey cell line)
Type of Samples Collected
-